Insulet Corporation

NASDAQ:PODD   3:59:50 PM EDT
281.29
-2.85 (-1.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.35B
Current PE635.07
Forward PE 827.32
2yr Forward PE 255.72
See more stats
Estimates Current Quarter
Revenue$232.79 Million
Adjusted EPS-$0.02
See more estimates
10-Day MA$270.08
50-Day MA$256.03
200-Day MA$219.97
See more pivots

INSULET CORP Stock, NASDAQ:PODD

600 TECHNOLOGY PARK, SUITE 200, BILLERICA, MA 01821
United States of America
Phone: 978-600-7000
Number of Employees: 1169

Description

Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.